Overactive Bladder/Enuresis Archives - Page 16 of 16 - Renal and Urology News

Overactive Bladder/Enuresis

Solifenacin Works for Difficult OAB

Patients with severely bothersome overactive bladder (OAB) symptoms who have failed treatment with tolterodine ER may benefit by switching to solifenacin, research suggests.

Once-Daily Formulation for OAB Treatment Approved

Sanctura XR (trospium chloride extended-release capsules), made by Indevus Pharmaceuticals, Inc., of Lexington, Mass., has been approved for the once-daily treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.

OAB in Men: A Diagnostic Challenge

Overactive bladder (OAB) is usually associated with women, but it afflicts nearly one out of every eight American men. Its symptoms can also be confused with those of BPH, resulting in unneeded surgery.

Duloxetine May Relieve OAB Symptoms

Duloxetine, a serotonin-noradrenalin reuptake inhibitor, may be an effective treatment for women with symptoms of overactive bladder (OAB). Duloxetine is marketed as Cymbalta for treating depression and diabetic peripheral neuropathy.

Next post in News